A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT07562022 · RECRUITING
Trial details
- NCT number
- NCT07562022
- Sponsor
- Sinocelltech Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-09
- Primary completion
- 2028-05-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.